APA (7th ed.) Citation

Medise, B. E., Windiani, I. G. A. T., Husada, D., Sekartini, R., Gunardi, H., Wirahmadi, A., . . . Sahastrabuddhe, S. (2025). One-month evaluation of safety and immunogenicity of a Vi-DT typhoid conjugate vaccine (Bio-TCV®) in Indonesian subjects 6 months to 45 years: A phase III randomized clinical trial. Vaccine: X, 25, 100661. https://doi.org/10.1016/j.jvacx.2025.100661

Chicago Style (17th ed.) Citation

Medise, Bernie Endyarni, et al. "One-month Evaluation of Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine (Bio-TCV®) in Indonesian Subjects 6 months to 45 years: A Phase III Randomized Clinical Trial." Vaccine: X 25 (2025): 100661. https://doi.org/10.1016/j.jvacx.2025.100661.

MLA (9th ed.) Citation

Medise, Bernie Endyarni, et al. "One-month Evaluation of Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine (Bio-TCV®) in Indonesian Subjects 6 months to 45 years: A Phase III Randomized Clinical Trial." Vaccine: X, vol. 25, 2025, p. 100661, https://doi.org/10.1016/j.jvacx.2025.100661.

Warning: These citations may not always be 100% accurate.